Jose Lozada-Lucio

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Trop-2 expression is associated with poor survival in pleural mesothelioma.

Trop-2 expression is associated with poor survival in pleural mesothelioma.

Journal: Frontiers in oncology
Published: March 28, 2026

Mitochondrial DNA in lung cancer: From biology to clinical implications.

Mitochondrial DNA in lung cancer: From biology to clinical implications.

Journal: Critical reviews in oncology/hematology
Published: March 20, 2026

Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort study.

Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort study.

Journal: Cancer treatment and research communications
Published: January 28, 2026

DNA damage response genes in lung cancer: Diagnostic, prognostic, and therapeutic implications - A narrative review.

DNA damage response genes in lung cancer: Diagnostic, prognostic, and therapeutic implications - A narrative review.

Journal: Critical reviews in oncology/hematology
Published: January 23, 2026

Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort study.

Clinical, diagnostic and prognostic relevance of GATA3 in malignant pleural mesothelioma: a retrospective cohort study.

Journal: BMC cancer
Published: January 06, 2026

Correction: Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Correction: Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Journal: Journal of translational medicine
Published: July 03, 2025

Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy.

Immunomodulatory role of oncogenic alterations in non-small cell lung cancer: a review of implications for immunotherapy.

Journal: Cancer metastasis reviews
Published: May 15, 2024

Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study.

Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 27, 2024

Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.

Journal: Journal of translational medicine
Published: March 25, 2024

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 26, 2023

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition.

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition.

Journal: International journal of molecular sciences
Published: December 30, 2022

Activities Performed by ASCO-Sponsored Oncology Student Interest Groups in Latin America: Assessing Members' Preferences and Leaders' Challenges.

Activities Performed by ASCO-Sponsored Oncology Student Interest Groups in Latin America: Assessing Members' Preferences and Leaders' Challenges.

Journal: JCO global oncology
Published: October 20, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026